fda approved glp-1 drugs for weight loss Comparing Ozempic, Wegovy and Other FDA Approves Oral Semaglutide: First

E., Dohna-Schwake, C., Hanssler, L., Neudorf, U., Hoyer, P

Moreover, the presence of diminished muscle mass and power, aberrant muscle quality characterized by increased fat or myosteatosis, electrolyte imbalances, malnutrition, subclinical myopathy, diminished motivation, memory, and concentration, alongside an array of mental health and sleep disorders directly linked to or associated with the underlying disease, further exacerbate, and contribute to fatigue in cirrhosis (9)

The decision to use Ozempic off-label should be based on sound medical judgment, consideration of the available evidence, and a thorough understanding of the patients individual needs

Fan J, Xu G, Jiang T, Qin Y